Molecule Structure

Scientific Name

Ketorolac

Description of the Drug

Ketorolac is an NSAID used to treat moderate to severe pain, rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, menstrual disorders, and headaches.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00465

Brand Name(s)

Not Available

Company Owner(s)

Roche Palo Alto Llc, Watson Laboratories Inc, Mylan Pharmaceuticals Inc, Atlantide Pharmaceuticals Ag, Akorn Operating Co Llc, Apotex Inc Richmond Hill, Bedford Laboratories Div Ben Venue Laboratories Inc, Teva Pharmaceuticals Usa Inc, Fresenius Kabi Usa Llc, Steriscience Pte Ltd

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Cyclooxygenase PROTEIN FAMILY INHIBITOR CHEMBL2094253

Unichem Links

SureChEMBL SCHEMBL14891
PharmGKB PA450150
Human Metabolome Database HMDB0014608
DrugBank DB00465
PubChem: Thomson Pharma 14774471
PubChem 3826
Mcule MCULE-3065255051
LINCS LSM-1526
Nikkaji J1.487.487I
BindingDB 85511
EPA CompTox Dashboard DTXSID8023189
DrugCentral 1529
Brenda 122879
ChemicalBook CB6392833
Guide to Pharmacology 6661
rxnorm ACULAR ACUVAIL KETOROLAC TROMETHAMINE SPRIX KETOROLAC
PubChem: Drugs of the Future 12013083
KEGG Ligand C07062
ChEBI 76223 6129